The $1M ALS Biomarker Prize Has Been Won!
News
|
Events
|
Digest
CALENDAR 2010-2011
(click to view highlighted events)
<
August 2010
>
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
<
September 2010
>
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
<table width="100%" border="0" cellspacing="0" cellpadding="0" bgcolor="#FFFFFF"> <tr> <td><span class=default> <!-- <div id="translate-this"><a href="http://translateth.is/" class="translate-this-button">Translate</a></div> <script type="text/javascript" src="http://www.google.com/jsapi"></script> <script type="text/javascript" src="http://x.translateth.is/translate-this.js"></script> <script type="text/javascript"> TranslateThis(); </script> --> <!-- startprint --> <span class=default><br><br><a href="http://www.prize4life.org/page/4081/0/0/20100801/" ><img src="graphics_custom/modules/news/news_back.gif" border="0"></a> <br><br> <span class="newsheadlinedetail">Neuralstem, Inc., receives FDA approval for Phase 1 ALS clinical trial</span><br> <i> Posted on: <span class="newsdatedetail">September 21, 2009</span></i><br><br> <span class="newsbody"><span style="font-family: 'Times New Roman'; font-size: 12pt"><span class="default"> <p><a title="" href="http://neuralstem.com/">Neuralstem, Inc</a>., a Maryland-based biotech company, announced that the FDA approved its application to conduct a Phase I safety trial of its stem-cell based approach to treat ALS, making it the first company to do so. Prize4Life congratulates Neuralstem for its impressive work, and is excited to see the FDA take this important step towards actualizing stem cells as a potentially promising therapy. Prize4Life also congratulates <a title="" href="http://www.brainstorm-cell.com/">BrainStorm Cell Therapeutics</a>, of Petach Tikva, Israel, for its recently-secured funding to complete pre-clinical stem cell trials for ALS. A <a title="" href="/page/prizes/registered_teams">competitor</a>for Prize4Life's Avi Kremer ALS Treatment Prize, BrainStorm expects to begin Phase I clinical trials in early 2010. </p> <p>Read Prize4Life's press release on Neuralstem's accomplishment <a title="" href="/uploaded_files/neuralstem_9cfwud.pr_9cfwud.final_9cfwud.pdf">here</a>. </p></span></span></span> <br><br> <a href="http://www.prize4life.org/page/4081/0/0/20100801/" ><img src="graphics_custom/modules/news/news_back.gif" border="0"></a> <!-- stopprint --> </span></td> </tr> </table>
